We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Clinical Updates

Evaluating the Long-Term Effects of Cocoa Extract Supplementation on the Development of Hypertension: Insights from the COSMOS Trial

MedXY Editorial Team•Sep 19, 2025•Clinical Updates
blood pressureHypertensionrandomized clinical trial

Highlight

– The COSMOS randomized clinical trial investigated the long-term impact of cocoa extract supplementation on incident hypertension in older adults.
– Overall, cocoa extract did not significantly reduce hypertension incidence over a median follow-up of 3.4 years.
– A notable 24% reduction in hypertension risk was observed among participants with baseline systolic blood pressure (SBP) below 120 mm Hg.
– The protective effect became apparent after two years of supplementation, highlighting a potential preventive role in normotensive individuals.

Study Background and Disease Burden

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier ModelsA randomized clinical trial demonstrated that the 5x-multiplier algorithm significantly reduces opioid prescriptions at discharge without increasing consumption, refill rates, or patient dissatisfaction after major abdominal cancer surgerySep 21, 2026Whole-grain Consumption and Cardiometabolic Risk: A Meta-analysis of Randomized TrialsThis meta-analysis of 87 randomized trials finds that increasing whole-grain intake is associated with improved cardiometabolic risk factors including reduced body weight, cholesterol, and blood pressure, particularly at daily intakes of 60Sep 21, 2026Unveiling the Role of Angiotensin II-Driven TGF-β1 in Enhancing Platelet PAR4 Expression and Thrombotic Risk in HypertensionThis study reveals that angiotensin II via TGF-β1 upregulates platelet PAR4, promoting hyperactivation and thrombosis in hypertension, with valsartan attenuating this pathway and thrombotic risk.Sep 21, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Intestinal Serotonergic Vagal Signaling: A Novel Link Between Gut Microbiota and Hypertension Management
Recent research identifies intestinal serotonin 5-HT3a receptor signaling via vagal neurons as a key mediator of microbiota-induced hypertension, offering new insights into resistant hypertension and potential therapeutic targets.
Sep 17, 2026
IVIG Plus Prednisone Enhances Recovery in Newly Diagnosed Idiopathic Inflammatory Myopathies: Insights from a Randomized Clinical TrialA recent randomized trial shows that adding intravenous immunoglobulin (IVIG) to high-dose prednisone significantly improves muscle strength and disease activity in newly diagnosed idiopathic inflammatory myopathies with rapid and clinicallSep 17, 2026
Impact of an AI-Powered Gamified Mobile Health Application on Blood Pressure Control in a Matched Patient CohortStudy found that use of an AI-driven gamified mobile app integrating home blood pressure monitoring significantly improved blood pressure control compared to usual care in hypertensive patients.Sep 17, 2026